Moreover, it is a superior FSHD biomarker to DUX4 target gene expression across microarray data sets, and at least as major a signature of FSHD skeletal muscle when considering RNA-seq data. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.